The Canada endometriosis treatment market size was estimated at USD 53.58 million in 2024 and is projected to reach USD 156.71 million by 2033, growing at a CAGR of 13.26% from 2025 to 2033. The growth is driven by increasing awareness, advancements in treatment options, improved healthc... Read More »
October 2025The global hematuria treatment market size was estimated at USD 1,087.3 million in 2024 and is projected to reach USD 1,426.9 million by 2033, growing at a CAGR of 3.1% from 2025 to 2033. The market is driven by urological care and sustained by the growing prevalence of recurrent urinary... Read More »
October 2025The U.S. asthma therapeutics market size was estimated at USD 13.00 billion in 2024 and is projected to reach USD 19.20 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The rising number of asthma patients in the U.S. has led to a growing demand for effective therapies, incl... Read More »
October 2025The global oral mucositis market size was estimated at USD 1.50 billion in 2024 and is projected to reach USD 2.85 billion by 2033, growing at a CAGR of 7.35% from 2025 to 2033. The rising clinical burden of Oral Mucositis (OM) is one of the major factors driving the market growth for or... Read More »
October 2025The global respiratory health supplements market size was estimated at USD 8.11 billion in 2024 and is projected to reach USD 15.57 billion by 2033, expanding at a CAGR of 7.7% from 2025 to 2033. The market expansion is driven by rising consumer awareness of preventive healthcare, increa... Read More »
October 2025The global pain management drugs market size was estimated at USD 78.84 billion in 2024 and is projected to reach USD 115.92 billion by 2033, growing at a CAGR of 4.38% from 2025 to 2033. The rising prevalence of chronic pain conditions across aging and lifestyle-affected populations dri... Read More »
October 2025The global epinephrine market size was valued at USD 2.87 billion in 2024 and is projected to reach USD 6.08 billion by 2033, growing at a CAGR of 8.71% from 2025 to 2033. The growth is attributed to rising allergy prevalence, greater public awareness of anaphylaxis, and expanding &ldquo... Read More »
October 2025The global complementary and alternative medicine market size was estimated at USD 179.17 billion in 2024 and is projected to reach USD 1430.70 billion by 2033, growing at a CAGR of 26.2% from 2025 to 2033. Growing awareness of Complementary and Alternative Medicine (CAM), rising disposa... Read More »
October 2025The global antipsychotic drugs market size was estimated at USD 17.53 billion in 2024 and is projected to reach USD 32.24 billion by 2033, growing at a CAGR of 6.1% from 2025 to 2033. The market is expanding due to the increasing prevalence of mental health disorders, greater awareness, ... Read More »
October 2025The global sciatica treatment market size was estimated at USD 5.15 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 8.40% from 2025 to 2033. This growth is attributed to several key factors, including the rising global prevalence of sciatica, agi... Read More »
October 2025The global necrotizing fasciitis market size was estimated at 1,027.24 million in 2024 and is projected to reach 2,097.81 million by 2033, growing at a CAGR of 8.3% from 2025 to 2033. The market is experiencing growth due to several key factors. Increasing awareness about the severity an... Read More »
October 2025The global pemphigus vulgaris market size was estimated at USD 481.3 million in 2024 and is projected to reach USD 975.2 million by 2033, growing at a CAGR of 8.2% from 2025 to 2033. Improved diagnostics & early detection, advancements in treatment modalities, and increasing R&D ... Read More »
October 2025The global bioanalytical testing services market size was estimated at USD 4.80 billion in 2024 and is projected to reach USD 11.24 billion by 2033, growing at a CAGR of 9.93% from 2025 to 2033. The market growth is due to increasing drug development activities and drug approval processe... Read More »
October 2025The global bone and joint health supplements market size was estimated at USD 14.17 billion in 2024 and is projected to reach USD 27.16 billion by 2033, growing at a CAGR of 7.57% from 2025 to 2033. Factors such as a rapidly growing geriatric population, the prevalence of orthopedic diso... Read More »
October 2025The U.S. artemisinic acid market size was estimated at USD 236.6 million in 2024 and is projected to reach USD 367.7 million by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The primary factors driving the U.S. artemisinic acid market include an increase in malaria cases connected t... Read More »
October 2025The global drug repurposing market size was estimated at USD 32.96 billion in 2024 and is projected to reach USD 47.40 billion by 2033, growing at a CAGR of 4.12% from 2025 to 2033. The market has gained significant traction, driven by the potential to offer both cost-effective and time-... Read More »
October 2025The global hepatitis therapeutics market size was estimated at USD 16.80 billion in 2024 and is projected to reach USD 23.62 billion by 2033, growing at a CAGR of 3.9% from 2025 to 2033. The global market is expanding as the prevalence of hepatitis B and C infections continues to pose a ... Read More »
September 2025The global intraoperative radiation therapy market size was estimated at USD 121.74 million in 2024 and is projected to reach USD 247.14 million by 2033, growing at a CAGR of 8.2% from 2025 to 2033. The intraoperative radiation therapy (IORT) market is expanding in response to the rising... Read More »
September 2025The global polycystic ovary syndrome supplements market size was valued at USD 1.20 billion in 2024 and is projected to reach USD 3.80 billion by 2033, growing at a CAGR of 14.29% from 2025 to 2033. The industry is gaining momentum due to the rising prevalence of polycystic ovary syndrom... Read More »
September 2025The global liposomal doxorubicin market size was estimated at USD 1.31 billion in 2024 and is projected to reach USD 2.38 billion by 2033, growing at a CAGR of 7.04% from 2025 to 2033. The rising number of cancer cases, particularly breast cancer, fuels the liposomal doxorubicin market.&... Read More »
September 2025